These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37177799)

  • 1. What do patients' efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry.
    Ruscheweyh R; Dresler T; Förderreuther S; Gaul C; Gossrau G; Jürgens TP; Ruschil V; Straube A; Scheidt J
    Cephalalgia; 2023 May; 43(5):3331024231174855. PubMed ID: 37177799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients.
    Ruscheweyh R; Klonowski T; Goßrau G; Kraya T; Gaul C; Straube A; Jürgens TP; Scheidt J; Förderreuther S
    J Headache Pain; 2022 Jul; 23(1):74. PubMed ID: 35773650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry.
    Ruscheweyh R; Gossrau G; Dresler T; Freilinger T; Förderreuther S; Gaul C; Kraya T; Neeb L; Ruschil V; Straube A; Scheidt J; Jürgens TP
    J Headache Pain; 2023 Oct; 24(1):135. PubMed ID: 37817093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for the acute treatment of migraine in children and adolescents.
    Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of medication-overuse headache according to the class of acute medication: A cross-sectional multicenter study.
    Oh SY; Kang JJ; Park HK; Cho SJ; Hong Y; Moon HS; Lee MJ; Song TJ; Im YJ; Son WJ; Roh YH; Chu MK
    Headache; 2022 Jul; 62(7):890-902. PubMed ID: 35833500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review.
    Deighton AM; Harris LA; Johnston K; Hogan S; Quaranta LA; L'Italien G; Coric V
    BMC Neurol; 2021 Nov; 21(1):425. PubMed ID: 34727873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
    Chiang CC; Fang X; Horvath Z; Cadiou F; Urani A; Poh W; Narimatsu H; Cheng Y; Dodick DW
    Neurology; 2023 Dec; 101(24):e2560-e2570. PubMed ID: 38030397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2022 Taiwan Guidelines for Acute Treatment of Migraine.
    Lau CI; Wang YF;
    Acta Neurol Taiwan; 2022 Jun; 31(2)():89-113. PubMed ID: 36153693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK; Banks J; Jones BA; Campbell J
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Self-medication of regular headache: a community pharmacy-based survey in Belgium].
    Mehuys E; Paemeleire K; Van Hees T; Christiaens T; Van Bortel L; Van Tongelen I; Philippe G; Prévôt ML; Evrard B; Piette M; De Bolle L; Remon JP; Boussery K
    J Pharm Belg; 2012 Jun; (2):4-10. PubMed ID: 22978009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the factors underlying discontinuation of triptans.
    Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.
    Friedman BW; Solorzano C; Esses D; Xia S; Hochberg M; Dua N; Heins A; Sasso P; Bijur PE; Lipton RB; Gallagher EJ
    Ann Emerg Med; 2010 Jul; 56(1):7-17. PubMed ID: 20303198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of medication overuse headache across classes of treatments for acute migraine.
    Thorlund K; Sun-Edelstein C; Druyts E; Kanters S; Ebrahim S; Bhambri R; Ramos E; Mills EJ; Lanteri-Minet M; Tepper S
    J Headache Pain; 2016 Dec; 17(1):107. PubMed ID: 27882516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Treatment Guidelines for Acute Migraine Attacks.
    Hsu YC; Lin KC; Taiwan Headache Society TGSOTHS
    Acta Neurol Taiwan; 2017 Jun; 26(2):78-96. PubMed ID: 29250761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor medical care for people with migraine in Europe - evidence from the Eurolight study.
    Katsarava Z; Mania M; Lampl C; Herberhold J; Steiner TJ
    J Headache Pain; 2018 Feb; 19(1):10. PubMed ID: 29392600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.